Everand Logo

Welcome to Everand!

  • STAT

    Before a biotech stock debacle, one Republican congressman made a prescient trade

    Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech's stock tanked. The stock was a favorite of several GOP representatives.
    by Damian Garde Jul 03, 2017 2 minutes
    Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech company's stock tanked.

    A biotech stock meltdown last week led to huge paper losses for several congressional Republicans who had bought into the tiny company. But one politician-turned-investor was spared. Turns out, he had sold his shares just two weeks before news of a negative clinical trial decimated the company’s value.

    Rep. John Culberson of Houston was among a half dozen House Republicans to invest in Innate Immunotherapeutics,

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.

    Related Books & Audiobooks